Pain mechanismRegulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes
Section snippets
Animals
Adult male Sprague–Dawley rats (weighing 200–220 g, from Experimental Animal Center, Shanghai Medical College, Fudan University, Shanghai, China) were allowed to acclimate for 1 week and maintained at a room temperature of 22±2 °C and a 12-h light/dark cycle with free access to food and water. The animal protocols were conducted according to the Animals Care and Use Committee of Shanghai Medical College, Fudan University, and conformed to the ethical guidelines of the International Association
Time course of behavioral hypersensitivity
Following a peripheral administration of CFA into the left hind paw, animals showed evident signs of inflammation, which were assessed by localized erythema and an increase in the swelling of the paw, and caused a decrease in hyperalgesia score to noxious thermal stimuli. The hyperalgesia score for thermal stimuli was significantly different from the saline-treated rats. The hyperalgesia score to thermal stimuli decreased markedly at 4 h, and 4, 10 and 14 days in the CFA-treated rats. The
Discussion
We report herein the temporal expression profile of specific proinflammatory cytokines and glial activation in a rodent model of chronic inflammatory pain. Astrocytes in normal CNS are basally active and carry out various functions, including regulation of extracellular ion and neurotransmitter concentrations, availability of neurotransmitter/neuromodulator precursors to nearby neurons and maintenance of extracellular pH. After a lesion, astrocytes undergo extensive hypertrophy of their cell
Conclusion
In summary, the present study showed that astrocyte activation and enhanced cytokine expression in the spinal cord might have a role in eliciting behavioral hypersensitivity. N/OFQ shared a close relationship with cytokines in the CNS. ORL1 receptor was expressed in cultured astrocytes of rat spinal cord. Further it was shown that N/OFQ had a regulatory effect on cytokines mRNA transcripts, which suggested that modulation of nociception by N/OFQ might be dependent on proinflammatory cytokines
Acknowledgment
This project was financially supported by the National Key Basic Research Program (No. 2005CB523306) and the Science Foundation of Shanghai Municipal Commission of Science and Technology (No. 02DZ19150-1).
References (47)
Involvement of chemokines in pain
Eur J Pharmacol
(2001)- et al.
Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type
Fed Eur Biochem Soc Lett
(1994) - et al.
Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat
J Neuroimmunol
(1997) - et al.
The role of neuroinflammation and neuroimmune activation in persistent pain
Pain
(2001) - et al.
Involvement of nociceptin/orphanin FQ and its receptor in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation
Brain Res
(2006) - et al.
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Pain
(1988) - et al.
HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS)
Pain
(2004) - et al.
Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons
Neuroscience
(1997) - et al.
Cytokine involvement in dynorphin-induced allodynia
Pain
(2000) - et al.
ORL1, a novel member of the opioid family
Fed Eur Biochem Soc Lett
(1994)
Effects of interelukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat
Exp Neurol
The role of astrocytes and microglia in persistent pain
Antihyperalgesic and morphine sparing actions of propentofylline following nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines
Pain
TNF alpha induces IL-6 production by astrocytes but not by microglia
Brain Res
Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia
Neurosci Lett
Lumbar catheterization of the spinal subarachnoid space in the rat
J Neurosci Methods
Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat
Brain Res
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain
Neuroscience
The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents
J Neuroimmunol
Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain
Neurochem Int
Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat
Pain
Characterization of cytokine-induced hyperalgesia
Brain Res
Spinal cord glia: new players in pain
Pain
Cited by (52)
Trifluoro-icaritin alleviates chronic inflammatory pain through α7nAChR-mediated suppression of HMGB1/NF-κB signaling in the spinal cord of rats
2022, Brain Research BulletinCitation Excerpt :Studies have shown that IL-10 can suppress the expression of pro-inflammatory cytokines such as IL-1β, TNF-α and IL-12 (Blackburn and Wherry, 2007), which may be related to the dynamic balance between pro-inflammatory cytokines and anti-inflammatory cytokines. The release of pro-inflammatory mediators and the loss of anti-inflammatory cytokines result in neuroimmune response (Fu et al., 2007), indicating that an imbalance in the cytokines micro-environment mediates regulating inflammatory pain. It is clear that some key pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α are implicated in inflammatory pain (Moniruzzaman et al., 2016), conversely, IL-10 is identified as a profound anti-inflammatory cytokine that is greatly expressed on microglia, which exhibits marked anti-nociception in inflammatory pain (Dai et al., 2019).
The role of gut-immune-brain signaling in substance use disorders
2021, International Review of NeurobiologyCitation Excerpt :The opioid-induced activation of glial cells could be mediated by binding at various opioid receptors expressed by glial cells. Previous work has shown that all four members of opioid receptors (μ, δ, κ and nociceptin receptors) are expressed by glial cells (Chao, Gekker, Hu, et al., 1996; Dobrenis, Makman, & Stefano, 1995; Eriksson, Hansson, & Rönnbäck, 1992; Fu, Zhu, Wang, & Wu, 2007; Gurwell, Duncan, Maderspach, et al., 1996; Maduna, Audouard, Dembélé, et al., 2019; Meyer, Paisley, Mohamed, et al., 2017; Mika, Popiolek-Barczyk, Rojewska, et al., 2014; Nam, Han, Lee, et al., 2018; Shrivastava, Cabrera, Chastain, et al., 2017; Woo, Bae, Nam, et al., 2018). However, whether or not these receptors mediate opioid-induced glial activation remains unclear.
Glial neuroimmune signaling in opioid reward
2020, Brain Research BulletinInvolvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?
2018, European Journal of PharmacologyElectroacupuncture inhibits NLRP3 inflammasome activation through CB2 receptors in inflammatory pain
2018, Brain, Behavior, and Immunity